Abstract
Hemodynamic derangements due to heart failure are associated with alterations in pharmacokinetics. Although use of mechanical circulatory support mitigates such derangements, little evidence is available regarding pharmacokinetics in patients with LVADs. A previous pharmacokinetic analysis of vancomycin among patients with LVADs observed a reduced volume of distribution and clearance compared with estimates based on population kinetics. A total of 28 adult patients with LVADs hospitalized between January 2014 and May 2018 who received vancomycin through a pharmacist dosing consult were included. Internal medicine patients without heart failure receiving vancomycin were enrolled in a 2:1 fashion to make a control group. Exclusion criteria were unstable renal function, ESRD, acute decompensation, cardiac surgery within the preceding 5 days, or weight >110 kg. No difference was observed in the proportion achieving goal trough (64% of LVAD patients vs 71% control patients, p = 0.50). However, mean trough was significantly higher among LVAD patients (23.4 mg/L vs 17.7 mg/L, p = 0.017). Furthermore, there was a significant difference in the distribution of trough levels (p = 0.025) with LVAD patients being more likely to attain level...Continue Reading
References
Nov 1, 1976·Clinical Pharmacokinetics·N L Benowitz, W Meister
Aug 1, 1988·Clinical Pharmacokinetics·F V Shammas, K Dickstein
Nov 1, 1987·American Heart Journal·R L Woosley
Jan 1, 1985·European Journal of Clinical Pharmacology·M A NaafsJ Silberbusch
Mar 3, 2007·Critical Care : the Official Journal of the Critical Care Forum·Ravindra L MehtaUNKNOWN Acute Kidney Injury Network
Jul 14, 2012·European Journal of Clinical Pharmacology·Yuko ShimamotoKatsuya Komori
Aug 31, 2012·The Annals of Pharmacotherapy·Douglas L JenningsCeleste Williams
Oct 9, 2012·Current Opinion in Infectious Diseases·Brett Janson, Karin Thursky
Jan 25, 2013·Clinical Pharmacokinetics·Ryuichi OgawaHirotoshi Echizen
Mar 13, 2014·The International Journal of Artificial Organs·Douglas L JenningsDavid E Lanfear
Sep 23, 2014·Journal of the American College of Cardiology·Jerry D EstepSherif F Nagueh
Sep 25, 2014·Clinical Pharmacokinetics·Ryuichi OgawaHirotoshi Echizen
Sep 20, 2017·Antimicrobial Agents and Chemotherapy·Natalie A FinchMichael J Rybak
Jun 10, 2018·Journal of Clinical Pharmacy and Therapeutics·R K TunneyH J DeAntonio